SEC-Registered Investment Adviser
Solas Bioventures Management, LLC
Registration facts are from the firm's Form ADV Part 1A as published by the SEC, latest filing dated October 1, 2026. Figures are firm-level: they describe the advisory firm, not any single offering.
Registration
- Status
- Approved
- Registered since
- November 19, 2025
- Principal office
- 412 Georgia Avenue, Suite 201, Chattanooga, TN 37403
- Organized as
- Limited Liability Company, DE
- Fiscal year end
- December
- Umbrella registration
- Yes, 1 relying adviser
- Other offices
- 1
- Website
- www.solasbio.com
Scale
- Regulatory AUM
- $165.0M
- Accounts
- 12
- Clients
- 0
- Employees
- 6, 5 in advisory roles
- Private funds advised
- 12
- Private fund gross assets
- $165.0M
- Fund types
- 12 venture capital funds
- Funds with Form D records
- 9 issuers in AltStreet's ledger, $123.1M reported sold across them
Business, clients and compensation, as filed
- Advisory activities
- portfolio management for pooled investment vehicles
- Compensated by
- a percentage of assets under management and performance-based fees
- Client types
- pooled investment vehicles (12)
- Related persons include
- a lawyer or law firm and a sponsor, general partner or managing member of pooled investment vehicles
Form ADV Item 11 disclosures
No yes answers on Item 11 as of the latest Form ADV (October 1, 2026). Item 11 covers the firm and its advisory affiliates.
Form D activity of the funds this firm advises, by year
9 issuers in AltStreet's EDGAR ledger are joined to this adviser through Form ADV Schedule D, with Form D filings from June 18, 2020 to January 16, 2025. Reported sold across them: $123.1M.Years are the year of each offering's first notice; sold and investors are the latest figures on each chain. Counts and totals only; the fund roster is in the terminal.
| First notice | Offerings | Reported sold | Investors |
|---|---|---|---|
| 2025 | 2 | $14.8M | 36 |
| 2024 | 5 | $38.0M | 96 |
| 2022 | 1 | $35.1M | 26 |
| 2020 | 1 | $35.1M | 88 |
Is this your firm? Verified Profiles give managers a structured channel for corrections, additional disclosures, and right of reply, without changing AltStreet's independent research. Learn about verification →
Source: SEC Form ADV via IARD (roster of October 6, 2026), matched to the platform by AltStreet analysts. Item 11 answers are as reported on the firm's Form ADV and cover the firm and its advisory affiliates; consult the firm's IAPD record for the Disclosure Reporting Pages. Brochure statements are the firm's own. Nothing on this page is investment advice.